×
ADVERTISEMENT
ADVERTISEMENT

Bharat Biotech aims to manufacture 1 billion nasal vaccines in 2022: Report

The company has currently sought permission for Phase-3 clinical trials after conducting trials to judge the protection levels in conjunction with intramuscular jabs
Last Updated : 27 December 2021, 11:04 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 27 December 2021, 10:04 IST

Follow us on :

Follow Us